Cargando…

Against pragmatism: on efficacy, effectiveness and the real world

Explanatory and pragmatic trials represent ends of a continuum of attitudes about clinical trial design. Recent literature argues that pragmatic trials are more informative about clinical care in the real world. Although there is place for more pragmatic studies to inform clinical practice and healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Kent, David M, Kitsios, Georgios
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715401/
https://www.ncbi.nlm.nih.gov/pubmed/19580642
http://dx.doi.org/10.1186/1745-6215-10-48
_version_ 1782169773012942848
author Kent, David M
Kitsios, Georgios
author_facet Kent, David M
Kitsios, Georgios
author_sort Kent, David M
collection PubMed
description Explanatory and pragmatic trials represent ends of a continuum of attitudes about clinical trial design. Recent literature argues that pragmatic trials are more informative about clinical care in the real world. Although there is place for more pragmatic studies to inform clinical practice and health policy decision-making, we are concerned that it is generally under-appreciated that extrapolating the results of broadly inclusive pragmatic trials to the care of real patients may often be as problematic as extrapolating the results of narrowly focused explanatory or efficacy trials. Simplistic interpretation of pragmatic trials runs the risk of driving harmful policies.
format Text
id pubmed-2715401
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27154012009-07-25 Against pragmatism: on efficacy, effectiveness and the real world Kent, David M Kitsios, Georgios Trials Commentary Explanatory and pragmatic trials represent ends of a continuum of attitudes about clinical trial design. Recent literature argues that pragmatic trials are more informative about clinical care in the real world. Although there is place for more pragmatic studies to inform clinical practice and health policy decision-making, we are concerned that it is generally under-appreciated that extrapolating the results of broadly inclusive pragmatic trials to the care of real patients may often be as problematic as extrapolating the results of narrowly focused explanatory or efficacy trials. Simplistic interpretation of pragmatic trials runs the risk of driving harmful policies. BioMed Central 2009-07-06 /pmc/articles/PMC2715401/ /pubmed/19580642 http://dx.doi.org/10.1186/1745-6215-10-48 Text en Copyright © 2009 Kent and Kitsios; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Kent, David M
Kitsios, Georgios
Against pragmatism: on efficacy, effectiveness and the real world
title Against pragmatism: on efficacy, effectiveness and the real world
title_full Against pragmatism: on efficacy, effectiveness and the real world
title_fullStr Against pragmatism: on efficacy, effectiveness and the real world
title_full_unstemmed Against pragmatism: on efficacy, effectiveness and the real world
title_short Against pragmatism: on efficacy, effectiveness and the real world
title_sort against pragmatism: on efficacy, effectiveness and the real world
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715401/
https://www.ncbi.nlm.nih.gov/pubmed/19580642
http://dx.doi.org/10.1186/1745-6215-10-48
work_keys_str_mv AT kentdavidm againstpragmatismonefficacyeffectivenessandtherealworld
AT kitsiosgeorgios againstpragmatismonefficacyeffectivenessandtherealworld